Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Division of Genetic Counseling, Kobe University Hospital, Kobe, Japan.
J Hum Genet. 2017 Sep;62(9):851-855. doi: 10.1038/jhg.2017.48. Epub 2017 Apr 27.
Adams-Oliver syndrome (AOS, OMIM; 100300) is a rare genetic disease characterized by aplasia cutis congenita, terminal transverse limb defects and cutis marmorata with vascular anomalies such as congenital heart defects. The etiology of this syndrome has remained largely unknown but defective Notch signaling during vascular formation has been suggested. Here we describe a sporadic Japanese newborn case with clinically diagnosed AOS. Trio whole-exome sequencing identified a de novo, novel, heterozygous missense mutation in the Delta-like 4 ligand gene (DLL4 c.572G>A, p.Arg191His) in the patient. DLL4 functions as a requisite ligand for NOTCH1 receptor, which is essential for vascular formation. Amino acid substitution of Arg191 to His was predicted by molecular models to interfere with direct binding between DLL4 and NOTCH1. DLL4 has recently been identified as a causative gene of an autosomal dominant type of AOS with milder symptoms. The case described here showed gradual recovery from skull defects after birth and no psychomotor developmental delay has been observed. This is the second report of an AOS case with DLL4 mutation, and the phenotypic characteristics between the two cases are compared and discussed.
Adams-Oliver 综合征(AOS,OMIM;100300)是一种罕见的遗传性疾病,其特征为先天性表皮发育不全、末端横断性肢体缺陷和大理石样皮肤,伴有先天性心脏缺陷等血管异常。该综合征的病因在很大程度上仍不清楚,但血管形成过程中 Notch 信号的缺陷已被提出。本文描述了一例散发性日本新生儿 AOS 临床诊断病例。三人间全外显子组测序在患者中发现了 Delta 样配体 4 基因(DLL4 c.572G>A,p.Arg191His)的从头、新型、杂合错义突变。DLL4 作为 NOTCH1 受体的必需配体,对血管形成至关重要。分子模型预测 Arg191 突变为 His 会干扰 DLL4 和 NOTCH1 之间的直接结合。DLL4 最近被确定为一种常染色体显性 AOS 致病基因,其症状较轻。本文描述的病例在出生后颅骨缺陷逐渐恢复,且未观察到精神运动发育迟缓。这是第二个报道的 DLL4 突变的 AOS 病例,对两个病例的表型特征进行了比较和讨论。
J Hum Genet. 2017-4-27
Am J Hum Genet. 2015-9-3
Am J Med Genet A. 2017-3
DNA Cell Biol. 2020-3-4
Pediatr Dermatol. 2017-9
Circ Cardiovasc Genet. 2015-8
Arch Argent Pediatr. 2014-6
Front Pediatr. 2025-3-3
J Dev Biol. 2025-1-25
Stem Cells Dev. 2021-6-15
Chin Med J (Engl). 2019-7-20
Am J Hum Genet. 2015-9-3
Circ Cardiovasc Genet. 2015-8
Biochem J. 2015-5-15
Am J Hum Genet. 2014-8-14
Cell Rep. 2013-11-14
Am J Hum Genet. 2013-3-21
Am J Hum Genet. 2012-8-10